Trial Profile
PMCJ-9 (BCG Connaught strain) phase III clinical study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs BCG (Primary)
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nippon Kayaku
- 08 May 2017 New trial record